| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Marcelo E Tolmasky | |
| Maria S Ramirez | |||
| P2860 | cites work | Intratympanic gentamicin for Ménière's disease or syndrome | Q24235857 |
| Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii | Q24606136 | ||
| Structure and Functional Diversity of GCN5-Related N-Acetyltransferases (GNAT) | Q26314426 | ||
| Bacterial GCN5-Related N-Acetyltransferases: From Resistance to Regulation | Q26773344 | ||
| Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections | Q26859978 | ||
| Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding | Q27013922 | ||
| Antibiotics that target protein synthesis | Q27025271 | ||
| X-ray structure of the AAC(6')-Ii antibiotic resistance enzyme at 1.8 A resolution; examination of oligomeric arrangements in GNAT superfamily members | Q27640518 | ||
| The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography | Q27640718 | ||
| Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB | Q27668103 | ||
| Structure of the phosphotransferase domain of the bifunctional aminoglycoside-resistance enzyme AAC(6′)-Ie-APH(2′′)-Ia | Q27684260 | ||
| Antibiotic Binding Drives Catalytic Activation of Aminoglycoside Kinase APH(2″)-Ia | Q27704833 | ||
| AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading | Q27860652 | ||
| Mycobacterial endocarditis: a comprehensive review | Q28080539 | ||
| Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance | Q28138065 | ||
| Aspirin to prevent gentamicin-induced hearing loss | Q28196808 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin | Q28327231 | ||
| Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice | Q28361166 | ||
| Identification and characterization of a novel aac(6')-Iag associated with the blaIMP-1-integron in a multidrug-resistant Pseudomonas aeruginosa | Q28535259 | ||
| Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives | Q36457035 | ||
| Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli | Q36485419 | ||
| novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa | Q36505262 | ||
| Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives | Q36575916 | ||
| Aminoglycosides: ancient and modern | Q36669328 | ||
| A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides | Q36726249 | ||
| Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm | Q36850490 | ||
| The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae | Q36870957 | ||
| Functional characterization of Tn1331 gene cassettes | Q36876964 | ||
| Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables | Q36892368 | ||
| In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme. | Q36949450 | ||
| Molecular Diversity and Plasmid Analysis of KPC-Producing Escherichia coli | Q37023201 | ||
| Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. | Q37058913 | ||
| Bacterial uptake of aminoglycoside antibiotics. | Q37063992 | ||
| A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure | Q37144903 | ||
| Aminoglycoside induced ototoxicity | Q37178103 | ||
| Inhibition of RNase P RNA cleavage by aminoglycosides | Q37199561 | ||
| Insights into functional modulation of catalytic RNA activity. | Q37219641 | ||
| mwr Xer site-specific recombination is hypersensitive to DNA supercoiling | Q37235322 | ||
| Complete nucleotide sequence of a blaKPC-harboring IncI2 plasmid and its dissemination in New Jersey and New York hospitals | Q37263753 | ||
| Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria | Q37304179 | ||
| Tackling antibiotic resistance: a dose of common antisense? | Q37323966 | ||
| Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats | Q37358621 | ||
| In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic | Q37392858 | ||
| Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone | Q37392921 | ||
| High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene | Q37450730 | ||
| Mechanisms of Evolution in High-Consequence Drug Resistance Plasmids | Q37481752 | ||
| Understanding and overcoming aminoglycoside resistance caused by N-6'-acetyltransferase | Q37528001 | ||
| Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy | Q37538644 | ||
| The bifunctional enzymes of antibiotic resistance | Q37555216 | ||
| Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program. | Q37624751 | ||
| Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease | Q37679776 | ||
| Inhibition of gene expression by RNase P. | Q37704699 | ||
| Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models | Q43710264 | ||
| Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation | Q43792968 | ||
| The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. | Q44236334 | ||
| Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi. | Q44248786 | ||
| Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery | Q44261322 | ||
| Kinetic mechanism of the GCN5-related chromosomal aminoglycoside acetyltransferase AAC(6')-Ii from Enterococcus faecium: evidence of dimer subunit cooperativity | Q44454184 | ||
| Therapeutic drug monitoring of amikacin in preterm and term infants. | Q44775313 | ||
| Domain-domain interactions in the aminoglycoside antibiotic resistance enzyme AAC(6')-APH(2''). | Q44993651 | ||
| A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae | Q45224934 | ||
| Aminoglycoside suppression of nonsense mutations in severe hemophilia | Q45885507 | ||
| Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy. | Q45972605 | ||
| Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis. | Q46078844 | ||
| Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles | Q46365690 | ||
| Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance | Q46408439 | ||
| Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial | Q46830300 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Characterization of a 30S ribosomal subunit assembly intermediate found in Escherichia coli cells growing with neomycin or paromomycin | Q46865187 | ||
| Making sense of antisense oligonucleotides: A narrative review | Q47438944 | ||
| Estimation of once-daily amikacin dose in critically ill adults | Q47917787 | ||
| High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland. | Q48040002 | ||
| A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6')-Ib | Q48052593 | ||
| qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location | Q48053181 | ||
| Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin Conjugates. | Q48334900 | ||
| The aacA-aphD gentamicin and kanamycin resistance determinant of Tn4001 from Staphylococcus aureus: expression and nucleotide sequence analysis | Q48336219 | ||
| Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates | Q49934971 | ||
| The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups | Q50136396 | ||
| GENTAMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA. | Q50272071 | ||
| Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli | Q39855726 | ||
| Primary structure of an aminoglycoside 6'-N-acetyltransferase AAC(6')-4, fused in vivo with the signal peptide of the Tn3-encoded beta-lactamase | Q39963396 | ||
| New agents for the treatment of infections with Gram-negative bacteria: Restoring the miracle or false dawn? | Q40052783 | ||
| Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital | Q40086702 | ||
| The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases | Q40100000 | ||
| Some effects of the aminoglycoside antibiotic amikacin on neuromuscular and autonomic transmission | Q40127875 | ||
| Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile | Q40283553 | ||
| Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031 | Q40284287 | ||
| Netilmicin: clinical pharmacokinetics and aspects on dosage schedules. An overview | Q40301498 | ||
| Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors | Q40338056 | ||
| Discovery and Optimization of Two Eis Inhibitor Families as Kanamycin Adjuvants against Drug-Resistant M. tuberculosis | Q40416937 | ||
| Sulfonamide-Based Inhibitors of Aminoglycoside Acetyltransferase Eis Abolish Resistance to Kanamycin in Mycobacterium tuberculosis | Q40433292 | ||
| Expanding Aminoglycoside Resistance Enzyme Regiospecificity by Mutation and Truncation | Q40543501 | ||
| Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms | Q40791217 | ||
| Aminoglycoside resistance mediated by the bifunctional enzyme 6'-N-aminoglycoside acetyltransferase-2"-O-aminoglycoside phosphotransferase | Q40830167 | ||
| Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli | Q40886398 | ||
| Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics | Q40942941 | ||
| Acetylation of amikacin, a new semisynthetic antibiotic, by Pseudomonas aeruginosa carrying an R factor | Q40943676 | ||
| R factor-mediated aminoglycoside antibiotic resistance in Pseudomonas aeruginosa: a new aminoglycoside 6'-N-acetyltransferase | Q40944201 | ||
| Amikacin in newborn infants: comparative pharmacology with kanamycin and clinical efficacy in 45 neonates with bacterial diseases | Q40947006 | ||
| In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains | Q40989330 | ||
| A Novel 6'-N-Aminoglycoside Acetyltransferase, AAC(6')-Ial, from a Clinical Isolate of Serratia marcescens. | Q41054137 | ||
| The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of the | Q41092604 | ||
| Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii? | Q41110741 | ||
| d-Tubocurarine and Berbamine: Alkaloids That Are Permeant Blockers of the Hair Cell's Mechano-Electrical Transducer Channel and Protect from Aminoglycoside Toxicity | Q41454597 | ||
| New plasmid-mediated aminoglycoside 6'-N-acetyltransferase, AAC(6')-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolate | Q41552003 | ||
| High-level gentamicin resistance mediated by a Tn4001-like transposon in seven nonclonal hospital isolates of Streptococcus pasteurianus | Q41844632 | ||
| Respiration-dependent uptake of dihydrostreptomycin by Escherichia coli. Its irreversible nature and lack of evidence for a uniport process | Q41929545 | ||
| Class II transposon-borne structure harboring metallo-beta-lactamase gene blaVIM-2 in Pseudomonas putida | Q42008852 | ||
| (Non-)translational medicine: targeting bacterial RNA | Q42276515 | ||
| Management of Aminoglycosides in the Intensive Care Unit | Q42908869 | ||
| A random sequential mechanism of aminoglycoside acetylation by Mycobacterium tuberculosis Eis protein | Q28541901 | ||
| Hitting bacteria at the heart of the central dogma: sequence-specific inhibition | Q28756986 | ||
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening | Q29617343 | ||
| Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies | Q30240026 | ||
| Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis | Q30479961 | ||
| High-copy bacterial plasmids diffuse in the nucleoid-free space, replicate stochastically and are randomly partitioned at cell division. | Q30569014 | ||
| Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series | Q30830192 | ||
| Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics | Q30874391 | ||
| Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report | Q31954204 | ||
| Aminoglycosides: nephrotoxicity | Q33605648 | ||
| Inhaled antibiotics for lower airway infections. | Q33640488 | ||
| Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection | Q33690206 | ||
| Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib by zinc: reversal of amikacin resistance in Acinetobacter baumannii and Escherichia coli by a zinc ionophore | Q33798534 | ||
| Modulation of RNA function by aminoglycoside antibiotics | Q33808338 | ||
| Aminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt | Q33831880 | ||
| Bacterial resistance to aminoglycosides and beta-lactams: the Tn1331 transposon paradigm | Q33854074 | ||
| Mutagenesis analysis of a conserved region involved in acetyl coenzyme A binding in the aminoglycoside 6'-N-acetyltransferase type Ib encoded by plasmid pJHCMW1. | Q33883705 | ||
| Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses | Q33977208 | ||
| Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin | Q33981379 | ||
| Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium. | Q33983032 | ||
| Uniform nomenclature for bacterial plasmids: a proposal | Q34071270 | ||
| Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa | Q34113541 | ||
| Synthesis and spectrum of the neoglycoside ACHN-490 | Q34134992 | ||
| Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1. | Q34142178 | ||
| Vestibular and cochlear toxicity of aminoglycosides--a review | Q34152908 | ||
| Neomycin and Paromomycin Inhibit 30S Ribosomal Subunit Assembly in Staphylococcus aureus | Q34271422 | ||
| Identification of a novel 6'-N-aminoglycoside acetyltransferase, AAC(6')-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia | Q34298833 | ||
| Structure of the bifunctional aminoglycoside-resistance enzyme AAC(6')-Ie-APH(2'')-Ia revealed by crystallographic and small-angle X-ray scattering analysis | Q34299292 | ||
| Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies | Q34353844 | ||
| Aminoglycoside modifying enzymes | Q34354185 | ||
| Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae | Q34410633 | ||
| Bacterial antisense RNAs: how many are there, and what are they doing? | Q34537427 | ||
| Paromomycin | Q34864208 | ||
| In vitro activity of plazomicin against 5,015 gram-negative and gram-positive clinical isolates obtained from patients in canadian hospitals as part of the CANWARD study, 2011-2012. | Q37712980 | ||
| Nocardiosis: updated clinical review and experience at a tertiary center | Q37715829 | ||
| The future of aminoglycosides: the end or renaissance? | Q37732085 | ||
| Development of aminoglycoside antibiotics effective against resistant bacterial strains | Q37771051 | ||
| New aminoglycoside antibiotics | Q37776523 | ||
| Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis | Q37783433 | ||
| Combating evolution with intelligent design: the neoglycoside ACHN-490 | Q37798897 | ||
| Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders | Q37825636 | ||
| 2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways | Q38062339 | ||
| Aminoglycosides: how should we use them in the 21st century? | Q38154113 | ||
| Biological metals and metal-targeting compounds in major neurodegenerative diseases | Q38237519 | ||
| Aminoglycoside-induced nephrotoxicity | Q38246945 | ||
| Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the gamma-amino-alpha-hydroxybutyryl (haba) group | Q38311956 | ||
| Cleavage of RNA oligonucleotides by aminoglycosides | Q38358167 | ||
| Once-daily dosing of amikacin for treatment of Mycobacterium abscessus lung disease. | Q38401736 | ||
| The Integron: Adaptation On Demand | Q38536095 | ||
| Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol | Q38740603 | ||
| In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents | Q38746761 | ||
| Aminoglycoside-induced nephrotoxicity in children | Q38795059 | ||
| Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies | Q38850670 | ||
| Antisense antimicrobial therapeutics | Q38885150 | ||
| Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review | Q38919674 | ||
| A systematic meta-analysis on the efficacy of pre-clinically tested nephroprotectants at preventing aminoglycoside nephrotoxicity. | Q39035269 | ||
| Mechanism and evidence of nonsense suppression therapy for genetic eye disorders | Q39074783 | ||
| Biosynthetic pathways of aminoglycosides and their engineering. | Q39213219 | ||
| Class 1 integrons as invasive species. | Q39246140 | ||
| Natural antisense RNAs as mRNA regulatory elements in bacteria: a review on function and applications | Q39325488 | ||
| Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates | Q39408544 | ||
| Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria | Q39487880 | ||
| Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusion | Q39651731 | ||
| Mechanism of bactericidal action of aminoglycosides. | Q39675399 | ||
| Salmonella enterica serovar Typhimurium bla(PER-1)-carrying plasmid pSTI1 encodes an extended-spectrum aminoglycoside 6'-N-acetyltransferase of type Ib. | Q39740503 | ||
| Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 | ||
| Inhibition of tobramycin diffusion by binding to alginate | Q39817978 | ||
| An overview of amikacin | Q39819199 | ||
| Transposon-mediated amikacin resistance in Klebsiella pneumoniae | Q39832338 | ||
| Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. | Q50457858 | ||
| New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues. | Q51444382 | ||
| Mg2+ mimicry in the promotion of group I ribozyme activities by aminoglycoside antibiotics. | Q52019131 | ||
| In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE). | Q52841787 | ||
| Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases. | Q53730038 | ||
| BB-K 8, a new semisynthetic aminoglycoside antibiotic | Q53854812 | ||
| Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. | Q53981567 | ||
| The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia. | Q54186249 | ||
| Dissemination of plasmid-mediated amikacin resistance among pathogenic Klebsiella pneumoniae. | Q54338152 | ||
| Plasmid-mediated resistance to gentamicin in Staphylococcus aureus: the involvement of a transposon. | Q54411258 | ||
| Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli. | Q54455872 | ||
| Effect of growth rate on streptomycin accumulation by Escherichia coli and Bacillus megaterium. | Q54470884 | ||
| Structures of aminoglycoside acetyltransferase AAC(6')-Ii in a novel crystal form: structural and normal-mode analyses. | Q54479918 | ||
| In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection. | Q54521821 | ||
| Role of ribosome recycling in uptake of dihydrostreptomycin by sensitive and resistant Escherichia coli | Q54539825 | ||
| Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacin | Q54612912 | ||
| 3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa | Q54668246 | ||
| Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis | Q57385370 | ||
| Aminoglycoside and aminocyclitol antibiotics: hygromycin B is an atypical bactericidal compound that exerts effects on cells of Escherichia coli characteristics for bacteriostatic aminocyclitols | Q67536438 | ||
| Action mechanism of 3',4'-dideoxykanamycin B (DKB) on Klebsiella pneumoniae | Q69369242 | ||
| The enigma of streptomycin transport | Q69679502 | ||
| Non-specific membrane permeability and aminoglycoside action | Q69723124 | ||
| Chromosome- and plasmid-mediated gentamicin resistance in Staphylococcus aureus encoded by Tn4001 | Q69807787 | ||
| Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius | Q71906321 | ||
| Mechanisms for negative regulation by iron of the fatA outer membrane protein gene expression in Vibrio anguillarum 775 | Q72079370 | ||
| [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus] | Q72154292 | ||
| Neuromuscular blocking activity of aminoglycoside antibiotics | Q72524080 | ||
| GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC COMPLEX | Q78289978 | ||
| External guide sequence technology: a path to development of novel antimicrobial therapeutics | Q36143151 | ||
| Combination therapy for treatment of infections with gram-negative bacteria | Q36156077 | ||
| Optimizing the initial amikacin dosage in adults | Q36158283 | ||
| Suppression of premature termination codons as a therapeutic approach. | Q36203719 | ||
| Sequencing and expression of the 6'-N-acetyltransferase gene of transposon Tn1331 from Klebsiella pneumoniae | Q36212292 | ||
| Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activiti | Q36249835 | ||
| Synthesis and Biological Activity of Mono- and Di-N-acylated Aminoglycosides | Q36281015 | ||
| Molecular understanding of aminoglycoside action and resistance | Q36360051 | ||
| Kanamycin: its discovery | Q78414645 | ||
| Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms | Q78434681 | ||
| CONTROL OF GRAM-NEGATIVE BACTERIA IN EXPERIMENTAL ANIMALS BY STREPTOMYCIN | Q81049091 | ||
| NMR-guided fragment-based approach for the design of AAC(6')-Ib ligands | Q81235414 | ||
| Aminoglycoside-induced ototoxicity | Q85318201 | ||
| Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China | Q87260032 | ||
| Assessment of configurations and chemistries of bridged nucleic acids-containing oligomers as external guide sequences: a methodology for inhibition of expression of antibiotic resistance genes | Q88786417 | ||
| Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit | Q89209050 | ||
| Complete nucleotide sequence of cfr-carrying IncX4 plasmid pSD11 from Escherichia coli | Q34923330 | ||
| Inhibitors of the aminoglycoside 6'-N-acetyltransferase type Ib [AAC(6')-Ib] identified by in silico molecular docking | Q34980567 | ||
| Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria | Q34982853 | ||
| Effects of Membrane-Energy Mutations and Cations on Streptomycin and Gentamicin Accumulation by Bacteria: a Model for Entry of Streptomycin and Gentamicin in Susceptible and Resistant Bacteria | Q34984041 | ||
| Mechanisms of antibiotic resistance | Q35053439 | ||
| Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm | Q35104348 | ||
| Versatility of aminoglycosides and prospects for their future | Q35176271 | ||
| Quantification of amikacin in bronchial epithelial lining fluid in neonates. | Q35191478 | ||
| Draft Genome of the Multidrug-Resistant Acinetobacter baumannii Strain A155 Clinical Isolate | Q35255727 | ||
| Mobility of gentamicin resistance genes from staphylococci isolated in the United States: identification of Tn4031, a gentamicin resistance transposon from Staphylococcus epidermidis | Q35344263 | ||
| Characterization of Tn6238 with a new allele of aac(6')-Ib-cr | Q35385866 | ||
| Tn1331, a novel multiresistance transposon encoding resistance to amikacin and ampicillin in Klebsiella pneumoniae | Q35562903 | ||
| High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake | Q35573156 | ||
| Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis | Q35573551 | ||
| Structure-activity relationships for antibacterial to antifungal conversion of kanamycin to amphiphilic analogues. | Q35590862 | ||
| Sublethal concentrations of the aminoglycoside amikacin interfere with cell division without affecting chromosome dynamics | Q35635646 | ||
| Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid | Q35651704 | ||
| Properties of an R plasmid in Pseudomonas aeruginosa producing amikacin (BB-K8), butirosin, kanamycin, tobramycin, and sisomicin resistance | Q35660594 | ||
| New plasmid-mediated aminoglycoside adenylyltransferase of broad substrate range that adenylylates amikacin | Q35670920 | ||
| Inhibition of aminoglycoside acetyltransferase resistance enzymes by metal salts | Q35746230 | ||
| Insertion Sequence IS26 Reorganizes Plasmids in Clinically Isolated Multidrug-Resistant Bacteria by Replicative Transposition | Q35753670 | ||
| Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium | Q35819363 | ||
| External guide sequences targeting the aac(6')-Ib mRNA induce inhibition of amikacin resistance | Q35840844 | ||
| Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents | Q35859918 | ||
| Increased resistance to amikacin in a neonatal unit following intensive amikacin usage | Q35893360 | ||
| Identification of an Inhibitor of the Aminoglycoside 6'-N-Acetyltransferase type Ib [AAC(6')-Ib] by Glide Molecular Docking | Q35955677 | ||
| Inhibition of AAC(6')-Ib-mediated resistance to amikacin in Acinetobacter baumannii by an antisense peptide-conjugated 2',4'-bridged nucleic acid-NC-DNA hybrid oligomer | Q35960810 | ||
| Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance in Klebsiella pneumoniae by zinc and copper pyrithione | Q35960865 | ||
| Molecular insights into aminoglycoside action and resistance | Q36034615 | ||
| Inhibition of Aminoglycoside 6′- N -Acetyltransferase Type Ib-Mediated Amikacin Resistance by Antisense Oligodeoxynucleotides | Q36048468 | ||
| Identification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosis | Q36107474 | ||
| Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece | Q36107990 | ||
| Molecular targets for design of novel inhibitors to circumvent aminoglycoside resistance | Q36109016 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | amikacin | Q408529 |
| carbohydrate | Q11358 | ||
| antibiotic | Q12187 | ||
| P577 | publication date | 2017-12-19 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Amikacin: Uses, Resistance, and Prospects for Inhibition. | |
| P478 | volume | 22 |
| Q90316700 | A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas |
| Q92723599 | Antimicrobial stewardship effectiveness on rationalizing the use of last line of antibiotics in a short period with limited human resources: a single centre cohort study |
| Q89673791 | Discordant bioinformatic predictions of antimicrobial resistance from whole-genome sequencing data of bacterial isolates: an inter-laboratory study |
| Q57052040 | Emergence of harboring the amikacin resistance gene |
| Q90369671 | Evaluation of the efficacy of antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in automated time-lapse microscopy and static time-kill experiments |
| Q53694871 | Plasticity of aminoglycoside binding to antibiotic kinase APH(2")-Ia. |
| Q91899108 | Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli |
| Q90442682 | Resensitization of Fluconazole-Resistant Urinary Candida spp. Isolates by Amikacin through Downregulation of Efflux Pump Genes |
| Q92374519 | Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc |
| Q92421800 | Synthesis of Ring II/III Fragment of Kanamycin: A New Minimum Structural Motif for Aminoglycoside Recognition |
| Q90369783 | Urinary Tract Infections among Bladder Outlet Obstruction Patients in Accra, Ghana: Aetiology, Antibiotic Resistance, and Risk Factors |
Search more.